Grannus Therapeutics
Redefining What's Possible in Targeted Cancer Therapy
Grannus Therapeutics was founded in 2019, is headquartered in Indianapolis, United States, and has $2.9M in recorded funding across 3 rounds.
- Headquarters
- Indianapolis, Indiana
- Founded
- 2019
- Business Model
- B2B
- Website
- grannustherapeutics.com
- Total Funding
- $2.9M
- Last Round
- $1.1M SeedFeb 2025
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.
About
Grannus Therapeutics is a pre-clinical stage biotechnology company developing first-in-class Hsp90β-selective inhibitors for the treatment of multiple solid tumors. Unlike prior pan-Hsp90 inhibitors that failed in clinical trials due to dose-limiting toxicities, Grannus's isoform-selective approach targets the beta version of the Hsp90 protein, delivering potent single-agent efficacy and enabling powerful combinations with approved therapies such as PARP inhibitors. The company's science is rooted in research from the University of Notre Dame and Purdue University, and it operates within the IDEA Center Innovation Park.
Summary
Grannus Therapeutics is a Healthcare company based in Indianapolis, United States, founded in 2019. It has raised $2.9M in total across 3 rounds, most recently a $1.1M Seed round in Feb 2025. Investors include Pit Road Fund, Plug and Play and Elevate Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2025
Sign up to see all 3 events
Funding: Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
China's leading blood products manufacturer
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/grannus-therapeutics"><img src="https://indexed.vc/api/badge/company/grannus-therapeutics" alt="Grannus Therapeutics on Indexed.vc" width="260" height="76" /></a>